Drawing on Experience to Shape the Future: 15 Years of Anti-TNFs
Highlights of a Symposium
A supplement to Rheumatology News International and supported by Schering-Plough.
The articles in this supplement are based on presentations made at a satellite symposium held on June 13, 2008 in Paris France.
2. Management of Rheumatoid Arthritis in the Age of Biologics
3. Use of Registry Data to Develop and Verify Rheumatoid Arthritis Treatment Strategies
4. Therapeutic Approaches for Achieving Rheumatoid Arthritis Remission Goals
5. Emerging Pharmacological Strategies for the Treatment of Rheumatoid Arthritis
Faculty/Faculty Disclosures
Iain B. McInnes, MD, PhD, FRCP - Chair Professor of Experimental Medicine
Honorary Consultant Rheumatologist
Glasgow Biomedical Research Centre
University of Glasgow
Glasgow, Scotland Professor McInnes has received honoraria, clinical grant funding, or has served on advisory boards for Schering-Plough Corporation.
Bernard Combe, MD, PhD Professor of Rheumatology/Head of the Division
Hopital Lapeyronie, Montpellier University Hospital
Montpellier, France Professor Combe has received honoraria or has served on advisory boards for Schering-Plough Corporation.
Georg Schett, MD Professor of Internal Medicine
University of Erlangen-Nuremberg
Department of Internal Medicine
Erlangen, Germany Professor Schett has nothing to disclose.
Ronald van Vollenhoven, MD, PhD Senior Physician and Associate Professor
Karolinska University Hospital
Rheumatology Unit
Stockholm, Sweden Professor van Vollenhoven has received clinical grant funding from Schering-Plough Corporation.
